New Peptide Strategy Blocks Liver Inflammation & Fibrosis
New Hope for Fatty Liver Disease: Peptide Therapies Show Promise The landscape of chronic liver disease is undergoing a potential transformation. Recent research highlights the effectiveness of peptide-based therapies in experimental models to halt the progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD). This groundbreaking research, published … Read more